CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- 4 Planned sale EVP R&D, Chief Medical Officer sold 14,349 shares at $30.77 ($441,550)
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure
- 144 Insider Sale of Securities
- 4 Planned sale SVP, Chief Commercial Officer sold 5,208 shares at $29.15 ($151,813)
- SC 13G Stake Amended Statement of Ownership
- 4 Planned sale EVP R&D, Chief Medical Officer sold 58,996 shares at $30.08 ($1,774,576)
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Planned sale EVP R&D, Chief Medical Officer sold 10,471 shares at $29.53 ($309,169)
- 144 Insider Sale of Securities
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 4 Shares withheld for taxes EVP, CLO, Alkermes, Inc. gave up 895 shares (to pay taxes)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 12 of 97 · 1,927 filings